Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids

Solution Overview

Problem

Traditional cannabinoid production through large-scale farming of Cannabis sativa L. is limited by uncontrollable environmental factors and scaling issues, necessitating an alternative, high-throughput production method.

Innovation Solution

Employing a bidirectional, multi-enzymatic scaffold in recombinant host cells to control enzyme localization, spatial orientation, and stoichiometry for optimized cannabinoid biosynthesis, utilizing engineered enzymes with heterologous interaction domains and peptide motifs to enhance cannabinoid production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional large-scale farming of Cannabis sativa L. is used for cannabinoid production, then production capacity can be maintained, but environmental factors become uncontrollable and scaling limitations occur

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent replaces the mechanical/agricultural system of Cannabis farming with a biochemical system using recombinant host cells. Instead of cultivating plants in controlled environments, the invention expresses cannabinoid biosynthetic enzymes in microbial or mammalian cell systems, allowing production to occur in bioreactors where environmental parameters (temperature, pH, nutrient supply) can be precisely controlled and scaled independently of agricultural constraints

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces recombinant host cells as intermediary systems between raw materials and final cannabinoid products. These engineered cells serve as biological factories that convert simple substrates into complex cannabinoid molecules through expressed biosynthetic pathways, eliminating the need for plant cultivation while maintaining production capacity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If non-scaffolded enzyme production methods are used, then device complexity is reduced, but cannabinoid yields are significantly lower

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent merges multiple individual enzyme molecules into a unified functional complex through scaffold proteins. The scaffold brings together enzymes from different biosynthetic pathways (e.g., polyketide synthase, terpenoid synthase, acyltransferase) into a single organized assembly, enabling efficient substrate channeling and increasing cannabinoid production rates beyond what dispersed enzymes can achieve

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent creates localized high-concentration zones of catalytic activity on the scaffold surface. By positioning specific enzymes at specific locations on the scaffold structure, the system creates micro-environments where substrates are efficiently funneled from one enzyme to the next, enhancing local reaction rates and overall pathway flux despite the added structural complexity

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly increases cannabinoid yields, including cannabigerolic acid, cannabidiolic acid, and cannabichromenic acid, by optimizing biosynthetic flux and localization, surpassing non-scaffolded enzyme production methods.

Implementation Method 1

enzymes catalyzing the biosynthesis of cannabinoids and cannabinoid precursors

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

each engineered enzyme includes a heterologous interaction domain, wherein the heterologous interaction domain comprises a first and a second peptide motif, and wherein each heterologous interaction domain is different from each other; and wherein the third exogenous nucleic acid encodes a polypeptide scaffold comprising a plurality of peptide ligands, wherein each peptide ligand comprises an amino acid sequence that can bind to the first or the second peptide motif of one of the heterologous interaction domains

Methodology Applied
Scientific EffectProtein-protein interaction: Adsorption

Data Source

PatentUS12385072B2Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids
Publication Date: 2025.08.12
  • US12385072B2 patent drawing
  • US12385072B2 patent drawing
  • US12385072B2 patent drawing

AI summary

This document relates to using bidirectional, multi-enzymatic scaffolds to biosynthesize cannabinoids in recombinant hosts.